US Government Takes Action to Lower Drug Prices by Seizing Patents of High-Priced Drugs

The Biden Administration has announced a new policy that allows the government to seize patents for medicines developed with government funding if their prices are deemed too high. This move creates a roadmap for the government's march-in rights, which have never been used before. Under the draft roadmap, the government will consider factors such as affordability and whether drugmakers are exploiting health or safety issues by increasing prices. The policy aims to ensure that taxpayer-funded drugs are available at reasonable prices and may grant additional licenses to third parties if the original patent holder does not comply. The public will have 60 days to comment on the proposal before it is finalized. The pharmaceutical industry has expressed concerns about the impact on innovation and patient access to medications.